Host: Megan Kruse, MD <br>


  
    <p>When treating patients with HER2-positive metastatic breast cancer, understanding how to monitor and manage potential side effects is essential for optimal care. Join Dr. Megan Kruse, a medical oncologist at Cleveland Clinic in Ohio, as she explains key considerations for managing side effects from tucatinib and trastuzumab deruxtecan.</p>

Host: Megan Kruse, MD When treating patients with HER2-positive metastatic breast cancer, understanding how to monitor and manage potential side effects is essential for optimal care. Join Dr. Megan Kruse, a medical oncologist at Cleveland Clinic in Ohio, as she explains key considerations for managing side effects from tucatinib and trastuzumab deruxtecan.

Optimizing Quality of Life in HER2+ Metastatic Breast Cancer

The Global Women's Health Academy (GWHA) series features late-breaking women's health education from leading clinical and public health experts across the world.
For more information about GWHA, visit www.globalwomenshealthacademy.org.

Medicine

The Global Women's Health Academy (GWHA) series features late-breaking women's health education from leading clinical and public health experts across the world. For more information about GWHA, visit www.globalwomenshealthacademy.org.

The&nbsp;Global Women's Health Academy&nbsp;(GWHA)&nbsp;series&nbsp;features late-breaking women's health education from leading clinical and public health experts across the world.
For more information about GWHA, visit&nbsp;www.globalwomenshealthacademy.org.

Share Optimizing Quality of Life in HER2+ Metastatic Breast Cancer

Sign up to save your podcasts

Optimizing Quality of Life in HER2+ Metastatic Breast Cancer

Optimizing Quality of Life in HER2+ Metastatic Breast Cancer